Comments
Commented by Armin Schulz on August 9th, 2023 | 08:55 CEST
Infineon, Globex Mining, PayPal - Where is it worth getting in after the setback?
The world of finance is characterized by constant fluctuations and changes. This dynamic, which is a source of uncertainty for some investors, can also provide opportunities to profit for well-informed shareholders. One such approach to profiting from the ups and downs of the financial markets is the art of "Buy the Dip" - taking advantage of setbacks or downturns in stock prices to invest cheaply in promising companies. This approach requires a solid understanding of market behavior and the ability to distinguish between temporary price corrections and long-term value potential. We have selected three candidates where an entry could be worthwhile.
Read
Commented by Stefan Feulner on August 9th, 2023 | 08:40 CEST
BYD, Defense Metals, Rheinmetall - Rare opportunities
In the race to meet climate targets, both politics and business are entering uncharted territory. The rapid departure from fossil fuels calls for alternative energy sources, increasing dependence on metallic raw materials, especially copper, cobalt, nickel and rare earth metals. But these essential resources, predominantly sourced from China, pose not only economic but also security challenges for the West, as they also play a key role in armaments.
Read
Commented by Fabian Lorenz on August 9th, 2023 | 07:00 CEST
After BioNTech shock: Evotec, Morphosys and Cardiol Therapeutics emerge as the new biotech favorites
BioNTech startled investors and analysts with its quarterly figures on Monday. Yet the biotech segment has actually developed positively in recent months. Several stocks are currently going full throttle, and S&P's sector index also outperformed the S&P 500 and MSCI World in July. This could finally signal the end of the underperformance of recent years, and biotech stocks could be celebrating a comeback. On the German stock charts, Evotec and Morphosys are among the high flyers. Both shares have performed strongly since April. Cardiol Therapeutics also looks promising from a technical chart perspective, and analysts see a price potential of over 200%. In contrast, there is currently no reason to buy BioNTech. Instead, investors should also bet on strength.
Read
Commented by André Will-Laudien on August 8th, 2023 | 09:50 CEST
Is Artificial Intelligence facing a crash? Facing the bear market with profit enthusiasm: BYD, VW, Nikola, and Power Nickel
The major stock markets reached new highs for the year last week. With interest rates continuing to rise, inflation still on the rise and recessionary tendencies, many market participants are wondering if the bull market will pause for a while. Because what has failed to materialize so far is a significant consolidation, which would be necessary to finally let off some steam and prevent losses of 20 to 50% within 6 weeks, as seen in 2000, 2008, 2011, 2015 and 2022. The respective starting points in those years were the volatile late summer months of August and September. Stocks such as Nividia, C3.ai and Palantir recently gained as much as 250% and have been buoyed by the AI wave. But how far can this trend go? Looking at the battery market, BYD, Nikola, and Power Nickel could be the next profit generators.
Read
Commented by Stefan Feulner on August 8th, 2023 | 09:15 CEST
Powerful movement through the flood of figures - Siemens Energy, Almonty Industries, Nio
The second quarter number season is at its peak, and surprises on both sides promise high volatility. BioNTech, the vaccine manufacturer, was hit hard after the end of the COVID-19 pandemic. Siemens Gamesa's wind power business also negatively affected the parent company's balance sheet. There are currently plenty of opportunities in the market, especially for traders.
Read
Commented by André Will-Laudien on August 7th, 2023 | 07:55 CEST
Wild times - quarterly figures on the move! Tupperware, Defence Therapeutics, PayPal and Amazon under the magnifying glass!
After a pronounced summer rally on the stock markets, there have been individual setbacks in early August. It should come as no surprise that the reaction to quarterly figures can sometimes be more intense. Often, stocks have simply run too far and experienced a healthy consolidation; in the case of Tupperware, the opposite is probably the case. Here, too many speculators have positioned themselves on the short side, and there were hopeful reports. We analyze a few highlights of the last week.
Read
Commented by Stefan Feulner on August 7th, 2023 | 07:25 CEST
Breakthroughs in the hydrogen sector - Nikola, First Hydrogen, Plug Power
Just last week, the German cabinet approved the update of the National Hydrogen Strategy from 2020, which is now being further developed to meet the increased level of ambition in climate protection and the new challenges in the energy market. Hydrogen is seen as the missing piece of the energy transition puzzle, and not just for Germany. Considerable progress has been made in the development of vehicles powered by hydrogen and fuel cells. At the same time, many innovative companies from this sector appear promising in the long term after the correction.
Read
Commented by Armin Schulz on August 7th, 2023 | 07:00 CEST
BP, Saturn Oil + Gas, Shell - Gains due to rising oil prices
The price of crude oil rose again last week. While Brent went out of trading on Friday at USD 85.45, the price for WTI stood at USD 81.53 per barrel. This could just be the beginning, as both Saudi Arabia and Russia have cut back production, which has tightened supply. In addition, US oil reserves fell by an unprecedented 17.1 million barrels, the most significant drop ever recorded. Only the downgrade of the US credit rating weighed a little on sentiment. But the risk that this will weigh on the economy seems small. The FED has let it be known that interest rates are not to rise for the time being, inflation is falling, and many company figures are above analysts' expectations. We, therefore, look at three oil producers that benefit from a rising oil price.
Read
Commented by Juliane Zielonka on August 4th, 2023 | 07:40 CEST
Saturn Oil + Gas, Vonovia, First Hydrogen, VW - How energy and propulsion are changing the markets, winners, and losers
Saturn Oil & Gas is adding three experienced forces to its leadership team. Janet Yang brings her expertise in finance and strategy, Andrew Claugus is a versatile petroleum engineer, and Grant MacKenzie will serve as Chief Legal Officer. Their knowledge and years of experience in the oil and gas industry make them valuable resources for the Company and its future development. Vonovia is severely undervalued due to the current real estate situation in Germany. First Hydrogen is making strides with a hydrogen refueling that covers a distance of 630 km, while Volkswagen is reducing the production of its electric car, ID.4. Let's find out who the winners and losers are in the stock market this time.
Read
Commented by André Will-Laudien on August 3rd, 2023 | 16:00 CEST
Uranium soon to be sanctioned? GoviEx Uranium, Plug Power, Nel ASA, AMS Osram - Can hydrogen solve the energy issue?
Somehow, energy policy has become very complicated. The EU sanctions coal, oil, gas and gold from Russia, but uranium remains untouched. Why? There is one who vehemently opposes this behind the scenes in Brussels: France! The German Minister of Economics, Robert Habeck, does not want to accept this. Of course, Germany no longer needs uranium for its decommissioned nuclear power plants, and the defense industry has its own sources of supply, which are not known to the public for security reasons. There is also the military coup in Niger, one of the world's major uranium-producing countries. What do investors have to pay attention to now?
Read